» Articles » PMID: 33463901

Stress Hyperglycemia, Cardiac Glucotoxicity, and Critically Ill Patient Outcomes Current Clinical and Pathophysiological Evidence

Overview
Journal Physiol Rep
Specialty Physiology
Date 2021 Jan 19
PMID 33463901
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Stress hyperglycemia is a transient increase in blood glucose during acute physiological stress in the absence of glucose homeostasis dysfunction. Its's presence has been described in critically ill patients who are subject to many physiological insults. In this regard, hyperglycemia and impaired glucose tolerance are also frequent in patients who are admitted to the intensive care unit for heart failure and cardiogenic shock. The hyperglycemia observed at the beginning of these cardiac disorders appears to be related to a variety of stress mechanisms. The release of major stress and steroid hormones, catecholamine overload, and glucagon all participate in generating a state of insulin resistance with increased hepatic glucose output and glycogen breakdown. In fact, the observed pathophysiological response, which appears to regulate a stress situation, is harmful because it induces mitochondrial impairment, oxidative stress-related injury to cells, endothelial damage, and dysfunction of several cellular channels. Paradigms are now being challenged by growing evidence of a phenomenon called glucotoxicity, providing an explanation for the benefits of lowering glucose levels with insulin therapy in these patients. In the present review, the authors present the data published on cardiac glucotoxicity and discuss the benefits of lowering plasma glucose to improve heart function and to positively affect the course of critical illness.

Citing Articles

Triglyceride-glucose index and the risk of in-hospital and ICU all-cause mortality: a systematic review and meta-analysis of observational studies.

Sharifi-Zahabi E, Nasiri N, Hajizadeh-Sharafabad F, Sharifi M, Saber A Nutr Diabetes. 2025; 15(1):8.

PMID: 39987150 PMC: 11846995. DOI: 10.1038/s41387-025-00366-x.


The U-shaped association of fasting plasma glucose to HbA1c ratio with mortality in diabetic and prediabetic populations: the mediating role of systemic immune-inflammation index.

Yang M, Shangguan Q, Xie G, Sheng G, Yang J Front Endocrinol (Lausanne). 2025; 16:1465242.

PMID: 39931237 PMC: 11807827. DOI: 10.3389/fendo.2025.1465242.


Retrospective observational study of the association of peak blood glucose during the second 24 hours of admission with hospital-acquired complications in non-critical care admissions to a tertiary referral teaching hospital.

Depczynski B, Kibret G, Georgiou A, Lau S BMJ Open. 2025; 15(1):e089652.

PMID: 39809558 PMC: 11752049. DOI: 10.1136/bmjopen-2024-089652.


The Interaction and Implication of Stress-Induced Hyperglycemia and Cytokine Release Following Traumatic Injury: A Structured Scoping Review.

Al-Hassani I, Khan N, Elmenyar E, Al-Hassani A, Rizoli S, Al-Thani H Diagnostics (Basel). 2024; 14(23).

PMID: 39682557 PMC: 11640098. DOI: 10.3390/diagnostics14232649.


The association between stress hyperglycemia ratio with mortality in critically ill patients with acute heart failure.

Ge T, Hu J, Zhou Y Front Cardiovasc Med. 2024; 11:1463861.

PMID: 39639971 PMC: 11617564. DOI: 10.3389/fcvm.2024.1463861.


References
1.
Giordano F . Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005; 115(3):500-8. PMC: 1052012. DOI: 10.1172/JCI24408. View

2.
Wahab N, Cowden E, Pearce N, Gardner M, Merry H, Cox J . Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol. 2002; 40(10):1748-54. DOI: 10.1016/s0735-1097(02)02483-x. View

3.
Srinivasan V . Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!. J Diabetes Sci Technol. 2012; 6(1):37-47. PMC: 3320820. DOI: 10.1177/193229681200600106. View

4.
Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S . Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med. 1993; 94(3):265-73. DOI: 10.1016/0002-9343(93)90058-w. View

5.
Szablewski L . Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol. 2016; 230:70-75. DOI: 10.1016/j.ijcard.2016.12.083. View